Page 25 - Key Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Plan. We see russia as a large, promising market. We wont change our mind. Theres more to be done in this market. And more warning signs out of china, investment, retail and factory data all disappointing in april with data hitting multiyear lows. Youre watching worldwide exchange, bringing you Business News from around the globe. And a warm welcome to tuesdays edition of worldwide exchange. Plenty to come through on the show today. Are you looking forward to it . Happy tuesday. Happy tuesday, everyone. Well get opecs latest report. Retail sales coming out of the u. S. As well. But before all ...

Label. These are troubling he looked ahead to next weeks. Fighting in the south of ukraine in the key port city of odessa which has avoided any violence up until now. The reports of as many as thirty people dead in a fire in the port area dozens of injuries there as well the situation remains volatile and ideas today for the first time Ukrainian Ministry forces moved against pro russia militias in the east is his heels of yet two minutes the helicopter went down to as there were a number of casualties. We will be going online. The reason for not to tell as kiev moves to restore its control in ...

And so hopefully its obvious to everyone here this 30 billion the 80 billion are deeply intertwined. In order for the private sector to make those investments there has to be raw material coming out of the basic research. Weve talked a lot about that. In order for that investment in basic research to create new cures, it has to be that investment in private sector r d to develop those scientific discoveries into cures for patients. So talking about that 80 billion is important and its also the benefit of not being quite zerosum game that we have to come up with government funding in order to s...

Or working with darpa as we are doing and with fda on this toxicity chip. Working on the brain initiative, a new effort which isugoing to be focused between nih and nsf and darpa and a number of private industries and philanthropies trying to make sure these kind of interdisciplinary efforts that jim was talking about are tapped into in every way. We are always looking at that. We are even looking at our peer review system to ask whether while we claim its the best in the world, are we sure about that . And are we sure our peer review system is reflecting the scientific opportunities of 2014 a...

I will say in years past jonathan in his work and much of the work that is being presented here when we were at meetings on innovation and the big bugaboo that ui is heard, the bogeyman, the fda. Fda is responsible for all the problems. Not true obviously and not what you hear now. I emailed some colleagues at the fda recently. I said interesting fda is not coming up at all. What is coming up is the specter of not being able to have products be reimbursed and so i think that is one that everybody can sort of lean in collectively and Start Talking about this value equation. To further comment o...